Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study

Marfella, R., D’Onofrio, N., Sardu, C., Scisciola, L., Maggi, P., Coppola, N., … Paolisso, G. (2022, January 1). Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study. Diabetes, Obesity and Metabolism. John Wiley and Sons Inc. https://doi.org/10.1111/dom.14547